DrugSafety

India's Cough Syrup Conundrum: A Half-Hearted Remedy for a Deeper Ailment

India's Latest Health Move: A Sweeping Ban on 'Irrational' Drug Combinations

India Takes a Stand: 16 Drug Combinations Banned for Patient Safety

Why Oxytocin Is Crucial for C‑Sections—and How Counterfeit Doses Endanger Mothers and Babies

BPC‑157: The Scientist Who’s Ready to Talk Skeptics

Kyle Diamantas Shines as Acting FDA Commissioner, Winning Trust Across the Board

Telangana's Crucial Crackdown on Unsafe Pharmacies

The Unfolding Saga: Inside the FDA's Scrutiny of the Abortion Pill

Beyond the Hype: India's Government Puts GLP-1 Weight Loss and Diabetes Drugs Under the Microscope

Kratom's Double-Edged Nature: As Calls to Poison Centers Skyrocket, What's the Real Story?

The Shadow Side of Breakthroughs: A Tragic Ozempic Lawsuit Unveils Concerns Over Patient Safety

The Silent Guardians: Unpacking the FDA's Vital Role in Drug Study Integrity

The Silent Threat: Unmasking the Crisis in Drug Safety Enforcement

A New Era for Patient Safety: EPS Corporation Elevates Pharmacovigilance with ArisGlobal's AI-Powered Solution

Bengaluru Gears Up for Vital New Drug Testing Lab, Promising Faster Results and Safer Medicines

Urgent Alert: High Blood Pressure Medication Recalled Due to Potential Cancer-Causing Impurity

Urgent Health Alert: Popular High Blood Pressure Medications Recalled Over Impurity Concerns

A Breakthrough in Drug Safety: Tessel Biosciences Secures Major ARPA-H Funding to Transform Drug Development

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

Urgent Health Alert: FDA Recalls Thousands of Topiramate Bottles Over Carcinogen Contamination

A New Era for Drug Safety: DiPharma Francis Publishes Groundbreaking Nitrosamine Detection Study

A Welcome Return: FDA Gives Green Light to Reformulated Ranitidine (Zantac) After Major Recall

Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures

The Bitter Truth: How Telangana is Fighting to Keep Our Medicines Safe

The Shadow Over the Pharma Giants: When Global Watchdogs Bark

The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag

Unearthing a Quiet Oversight: The FDA's Bold Move to Reclaim Trust in Medicine

Beyond the Buzz: Unpacking the Persistent Myth of Acetaminophen and Autism

A Disturbing Discovery: America's Most Prescribed Diabetes Drug Faces a Widespread Recall

The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety

Urgent Pharmacy Alert: Check Your Amoxicillin — A Packaging Mix-Up You Can't Ignore

A Shadow in Your Pills? Unpacking the Latest Blood Pressure Medication Recall

Health Alert: Your Blood Pressure Meds Might Be Part of a Nationwide Recall

A Pill of Doubt: When Lifesaving Drugs Turn Tainted and Trust is Shaken

The Unsettling Truth: Another Blood Pressure Drug Recalled Over Cancer Concerns

A Troubling Wave: Kamsack Confronts a Deadly New Reality on Its Streets

Navigating the Global Drug Safety Labyrinth: How Nippon Shinyaku is Revolutionizing Pharmacovigilance

The FDA's Mifepristone Review: A Political Maneuver Masquerading as Science?